Innixi is developing a new drug for Premature Ejaculation.
Clinical PoC already proven for this class and indication
First to market Priligy a success until black box syncope removed it from market
Using a Swedish CRO that developed Priligy - gives de-risked route to Phase II
and commercial partner.
Financing of $3M thu end 2017 & $6.5M thru end 2019
Overall total $14M in <4years to exit upon commercial sale to Pharma